AIDS researchers emphasize new drug combinations.
Fox
J L
JL
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D015195:Drug Design; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D017410:Practice Guidelines as Topic; D011994:Recombinant Proteins; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D011994:Recombinant Proteins; D018894:Reverse Transcriptase Inhibitors; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim